Enlitic (ASX:ENL) Buyback Yield %: -228.66 (As of Jul. 04, 2026)


What is Enlitic Buyback Yield %?

Enlitic ASX:ENL +20.00% Buyback Yield % is -228.66 as of Jul. 04, 2026. The stock has 2 warning signs investors should review. Among 272 Healthcare Providers & Services companies, Enlitic ranks worse than 99.26% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Enlitic's current buyback yield was -228.66%.

Enlitic Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Enlitic's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enlitic Buyback Yield % Chart

Enlitic Annual Data
Trend Dec23 Dec24 Dec25
Buyback Yield %
-48.38 -65.30 -63.52

Enlitic Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % 0.00 -0.02 -65.30 -173.60 -63.52

ASX:ENL vs VEEV, BTSG, TEM: Buyback Yield % Comparison

For the Health Information Services subindustry, Enlitic's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enlitic Buyback Yield % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Enlitic's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Enlitic's Buyback Yield % falls into.


Enlitic Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Enlitic's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-0.883 + 10.409) / 14.99715
=-63.52%

Enlitic's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-0.883 + 10.409) / 14.99715
=-63.52%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -228.66 mean?
Enlitic (ASX:ENL) has a Buyback Yield % of -228.66 as of Jul. 04, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Enlitic and its competitors. According to the industry distribution chart, Enlitic ranks #270 out of 272 companies in the Healthcare Providers & Services industry, placing it in the top 99.3%.
Is Enlitic's Buyback Yield % too high?
Enlitic's current Buyback Yield % is -228.66. Based on the distribution chart, Enlitic ranks #270 out of 272 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Enlitic's Buyback Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Enlitic ranks #270 out of 272 companies for Buyback Yield %. This places Enlitic in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Enlitic and its competitors. Enlitic's current Buyback Yield % is -228.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enlitic stock overvalued right now?
Enlitic (ASX:ENL) has a current Buyback Yield % of -228.66. The current Buyback Yield % is -228.66. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Enlitic (ASX:ENL), the current Buyback Yield % is -228.66 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enlitic Business Description

Address 1635 Foxtrail Drive, Suite 111A, Loveland, CO, USA, 80538
Enlitic Inc is the AI-enabled healthcare revolution. The company has developed an intelligent data framework that powers critical workflows, orchestrates data, and enables greater comprehension of what information resides in archives thereby unlocking new revenue opportunities, generating cost savings, and improving healthcare delivery. It provides solutions for Radiologists, IT Professionals, Executives, and Researchers. The Group has two operating segments: Software includes intelligently managing healthcare data using the power of artificial intelligence to expand capacity and improve clinical workflows, etc; and Migration services Transfer large volumes of imaging data to allow for the smooth transition of software solutions for healthcare vendors and providers and Migration services.